Why We Start with National Institutes of Health Research, Not Marketing Trends

When most skincare companies develop products, they start with market trends, competitor analysis, and consumer surveys. At Keys, we start with the National Institutes of Health research databases. Today, let's talk about why that matters.The N I H maintains the world's largest biomedical research library—hundreds of thousands of peer-reviewed studies on botanical compounds, skin barrier function, antimicrobial activity, anti-inflammatory pathways. This isn't marketing content. It's scientific validation accumulated over decades.When we claim neem oil has broad-spectrum antimicrobial activity, we're not making it up—we're referencing over 300 published studies indexed in N I H databases. When we describe zinc oxide as a wound-healing mineral with anti-inflammatory properties, we're citing decades of dermatological research validated by the F D A .Here's the difference: the F D A doesn't require pre-market safety testing for personal care products. That means most skincare on shelves has never been independently verified for safety or efficacy. Companies can make almost any claim without proving it.Keys takes the opposite approach. Every active botanical in our formulas—black seed oil's thymoquinone, avocado oil's beta-sitosterol, betulinic acid's collagen-stimulating properties—has been selected based on compounds and mechanisms documented in NIH-indexed research.This isn't just about feeling good about ingredients. It's about delivering results that are predictable, measurable, and reproducible—because the biological mechanisms are understood at the molecular level.That's clinical credibility. That's why we start with science, not sentiment.